Lung cancer study questions if lower chemo doses harm older patients

NCT ID NCT07369596

Recruiting now Knowledge-focused Sponsor: University of Malaya Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving older lung cancer patients a lower dose of chemotherapy affects how long they live. Researchers will compare survival between patients who got standard doses and those who got reduced doses. The goal is to understand if dose reductions are safe and effective for people aged 65 and older with advanced non-small cell lung cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CARCINOMA NSCLC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON SMALL CELL LUNG CARCINOMA NSCLC

Contacts and locations

Locations

Hospital Tengku Ampuan Afzan
RECRUITING

Kuantan, Pahang, Malaysia
Hospital Wanita dan Kanak-Kanak Sabah
RECRUITING

Kota Kinabalu, Sabah, Malaysia
Queen Mary Hospital, The University of Hong Kong
RECRUITING

Hong Kong, Hong Kong
Universiti Malaya Medical Centre
RECRUITING

Kuala Lumpur, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.